Abstract Introduction: The American Thyroid Association appointed a Task Force of experts
to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the …

Medullary thyroid carcinoma (MTC) is a rare type of tumor that originates from thyroid C cells
and accounts for 2–4% of all malignant thyroid neoplasms. MTC may occur sporadically or …

Purpose: Positive results of phase I studies evaluating lenvatinib in solid tumors, including
thyroid cancer, prompted a phase II trial in advanced medullary thyroid carcinoma (MTC) …

Background Medullary thyroid carcinoma (MTC) is a malignant tumour derived from the para-
follicular thyroid C cells. It may occur in sporadic or hereditary forms and surgery represent …

Purpose This phase II study investigated the efficacy and tolerability of motesanib, an
investigational, highly selective inhibitor of vascular endothelial growth factor receptors 1, 2 …

Some cancer types are strongly associated with chronic inflammatory or infectious diseases
whereas others are not, but an inflammatory component is present in most human neoplastic …

The Kirsten rat sarcoma viral oncogene homolog (RAS)/v-raf-1 murine leukemia viral
oncogene homolog 1 (RAF)/mitogen-activated protein kinase 1 (MAPK) signaling cascade is …

Objective The progression of medullary thyroid cancer is difficult to assess with imaging
modalities; we studied the interest of calcitonin and carcinoembryonic antigen (CEA) …

Prediction of remission in medullary thyroid carcinoma (MTC) depends on histopathological
information often unavailable before surgery. Simply requiring a venous blood sample …

Purpose: Because calcitonin level remains elevated after initial treatment in many medullary
thyroid carcinoma (MTC) patients without evidence of disease in the usual imaging work-up …